Tocilizumab Therapy of COVID-19: A Comparison of Subcutaneous and Intravenous Therapies. Kaminski MA, Sunny S, Balabayova K, Kaur A, et al. Int J Infect Dis 2020 Sep 28. pii: S1201-9712(20)32164.

Read + Share

Amedeo Smart

Independent Medical Education

Kaminski MA, Sunny S, Balabayova K, Kaur A, et al. Tocilizumab Therapy of COVID-19: A Comparison of Subcutaneous and Intravenous Therapies. Int J Infect Dis 2020 Sep 28. pii: S1201-9712(20)32164.
PMID: 33002613